ArticleACS pharmacology & translational science2026
Proteolysis Targeting Chimera (PROTAC) Linkerology Enhances the CDK-Degradation Selectivity Profile of a Multi-CDK Inhibitor: Discovery of Potent, Anti-Leukemic CDK9 Degraders.
Alexandria M Chan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.